PDE6B and retinal degeneration: The neuroprotective effects of CN03 were confirmed on several retinal degeneration models, i.e., rd10, rd1, and rd2, in vitro on retinal explants and in vivo using a delivery system based on glutathione-targeted PEGylated liposomes (LP-CN03) able to cross the BRB.